London, United Kingdom

Jonathan C Kentish

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Aop Orphan IP Ag. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan C Kentish. Retrieved from https://idiyas.com/inventor/jonathan-c-kentish

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jonathan C Kentish

Introduction

Jonathan C Kentish is a notable inventor based in London, GB. He has made significant contributions to the field of cardiology through his innovative patent. His work focuses on improving cardioplegia, which is crucial for heart surgeries.

Latest Patents

Jonathan holds a patent for "Compositions for use in cardioplegia comprising esmolol and adenosine." This invention relates to a composition that includes (i) esmolol and (ii) adenosine. In use, the concentration of esmolol ranges from 0.3-1.5 mM, while the concentration of adenosine is between 0.1-1.5 mM. The patent also covers methods for making and using these compositions, showcasing his innovative approach to enhancing cardiac care. He has 1 patent to his name.

Career Highlights

Throughout his career, Jonathan has worked with various companies, including AOP Orphan IP AG and Fallouh, Hazem. His experience in these organizations has contributed to his expertise in the field of medical innovations.

Collaborations

Some of his notable coworkers include David J Chambers and Hazem Bahaa Fallouh. Their collaboration has likely played a role in advancing his research and development efforts.

Conclusion

Jonathan C Kentish is a distinguished inventor whose work in cardioplegia has the potential to significantly impact cardiac surgery practices. His innovative compositions and methods reflect his dedication to improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…